InsidersTradesSigma
之江生物: directors' dealings · France · AMF
Explore the full management transaction log of 之江生物, a listed equity based in France. Shares trade on FR FR, under the authority of AMF. Operating in the Health Care sector, 之江生物 has recorded 5 insider filings. Market capitalisation: €3.9bn. The latest transaction was filed on 5 February 2024 (Purchase). Among the most active insiders: 邵俊斌. All data is free.
5
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
·
0 ops.
Sell Volume
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 5 February 2024
Declarations5 total
5 of 5 declarations